1h Free Analyst Time
The animal sedative market is poised to grow by $190.96 mn during 2022-2026, accelerating at a CAGR of 5.85% during the forecast period. The report on the animal sedative market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of animal diseases, growing applications of animals in medical research, and growing investment in R and D activities.
The animal sedative market analysis includes type segment and geographic landscape.
The animal sedative market is segmented as below:
By Type
- Parenteral
- Oral
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing adoption of pet animals as one of the prime reasons driving the animal sedative market growth during the next few years. Also, rising expenditure on veterinary care and enhancing the quality of care in animals during diagnosis and surgical procedures will lead to sizable demand in the market.
The report on the animal sedative market covers the following areas:
- Animal sedative market sizing
- Animal sedative market forecast
- Animal sedative market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal sedative market vendors that include Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG, and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group. Also, the animal sedative market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global animal sedative market: Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG, and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing adoption of pet animals.`
According to the report, one of the major drivers for this market is the increasing prevalence of animal diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Akorn Operating Co. LLC
- AmerisourceBergen Corp
- Bayer AG
- Bimeda Inc.
- C. H. Boehringer Sohn AG and Co. KG
- Ceva Sante Animale
- Chanelle Pharma Group
- Dechra Pharmaceuticals Plc
- Elanco Animal Health Inc.
- Jurox Pty Ltd.
- Konig SA
- Laboratorios Richmond
- Merck KGaA
- Modern Veterinary Therapeutics LLC
- Randlab Pty Ltd.
- Troy Laboratories Pty Ltd.
- Virbac Group
- Zoetis Inc.
- Orion Corp.
- Ouro Fino Saude Animal Group
